Cargando…

Rationale for the Use of Anticholinergic Agents in Overactive Bladder With Regard to Central Nervous System and Cardiovascular System Side Effects

PURPOSE: Central nervous system (CNS) and cardiovascular system (CVS) side effects of anticholinergic agents used to treat overactive bladder (OAB) are underreported. Hence, this review aimed to focus on the mechanisms of CNS and CVS side effects of anticholinergic drugs used in OAB treatment, which...

Descripción completa

Detalles Bibliográficos
Autores principales:	Çetinel, Bülent, Onal, Bulent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Urological Association 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866282/ https://www.ncbi.nlm.nih.gov/pubmed/24363860 http://dx.doi.org/10.4111/kju.2013.54.12.806

Ejemplares similares

Effect of Desmopressin with Anticholinergics in Female Patients with Overactive Bladder
por: Han, Young Kook, et al.
Publicado: (2011)

Refractory overactive bladder: Beyond oral anticholinergic therapy
por: Glinski, Ronald W., et al.
Publicado: (2007)

Cognitive Effects of Anticholinergic Load in Women with Overactive Bladder
por: Araklitis, George, et al.
Publicado: (2020)

The Impact of Gene Polymorphisms on the Success of Anticholinergic Treatment in Children with Overactive Bladder
por: Gurocak, Serhat, et al.
Publicado: (2015)

Mirabegron and Anticholinergics in the Treatment of Overactive Bladder Syndrome: A Meta-analysis
por: Sartori, Luisa Gracio Ferreira, et al.
Publicado: (2023)

The Efficacy and Safety of Propiverine Hydrochloride in Patients with Overactive Bladder Symptoms Who Poorly Responded to Previous Anticholinergic Agents
por: Masumori, Naoya, et al.
Publicado: (2011)

Anticholinergic Burden and Associated Healthcare Resource Utilization in Older Adults with Overactive Bladder
por: Jaggi, Ashley, et al.
Publicado: (2021)

Health Resource Utilization and Cost for Patients with Incontinent Overactive Bladder Treated with Anticholinergics
por: Yehoshua, Alon, et al.
Publicado: (2016)

Serum Anticholinergic Activity: A Possible Peripheral Marker of the Anticholinergic Burden in the Central Nervous System in Alzheimer's Disease
por: Hori, Koji, et al.
Publicado: (2014)

Augmentation cystoplasty in neurogenic bladder
por: Çetinel, Bülent, et al.
Publicado: (2016)

Clinical Efficacy in the Treatment of Overactive Bladder Refractory to Anticholinergics by Posterior Tibial Nerve Stimulation
por: Arrabal-Polo, Miguel Angel, et al.
Publicado: (2012)

Efficacy and Tolerability of Anticholinergics in Korean Children with Overactive Bladder: A Multicenter Retrospective Study
por: Park, Se Jin, et al.
Publicado: (2014)

Monotherapy with mirabegron had a better tolerance than the anticholinergic agents on overactive bladder: A systematic review and meta-analysis
por: Yi, Wei, et al.
Publicado: (2021)

Overactive Bladder Symptoms Within Nervous System: A Focus on Etiology
por: Qin, Chuying, et al.
Publicado: (2021)

Erratum: Efficacy and Tolerability of Anticholinergics in Korean Children with Overactive Bladder: A Multicenter Retrospective Study
por: Park, Se Jin, et al.
Publicado: (2015)

Fall/Fracture-Related Healthcare Costs and Their Association with Cumulative Anticholinergic Burden in People with Overactive Bladder
por: Lozano-Ortega, Greta, et al.
Publicado: (2020)

Patient and Clinician Challenges with Anticholinergic Step Therapy in the Treatment of Overactive Bladder: A Narrative Review
por: Dmochowski, Roger R., et al.
Publicado: (2023)

Comparison of reversal and adverse effects of sugammadex and combination of — Anticholinergic-Anticholinesterase agents in pediatric patients
por: Özgün, Çiğdem, et al.
Publicado: (2014)

Comparison of solifenacin and fesoterodine in treatment of overactive bladder
por: Ercan, Önder, et al.
Publicado: (2015)

Efficacy and Safety of Intravesical OnabotulinumtoxinA Injection on Elderly Patients with Chronic Central Nervous System Lesions and Overactive Bladder
por: Jiang, Yuan-Hong, et al.
Publicado: (2014)

The Rationale of Malaria Treatment in Syphilis of the Central Nervous System
por: Brooks, A. G.
Publicado: (1928)

Giant Multilocular Cystadenoma of the Prostate: A Rare Cause of Huge Cystic Pelvic Mass
por: Olgun, Deniz Cebi, et al.
Publicado: (2012)

Temporary cognitive impairment related to administration of newly developed anticholinergic medicines for overactive bladder: two case reports
por: Shiota, Takako, et al.
Publicado: (2014)

Adherence and persistence of mirabegron and anticholinergic therapies in patients with overactive bladder: a real‐world claims data analysis
por: Sussman, D., et al.
Publicado: (2017)

The Impact of Anticholinergic Use for Overactive Bladder on Cognitive Changes in Adults with Normal Cognition, Mild Cognitive Impairment, or Dementia
por: Welk, Blayne, et al.
Publicado: (2022)

OnabotulinumtoxinA 100U provides significant improvements in overactive bladder symptoms in patients with urinary incontinence regardless of the number of anticholinergic therapies used or reason for inadequate management of overactive bladder
por: Sievert, K-D, et al.
Publicado: (2014)

Association between cumulative anticholinergic burden and falls and fractures in patients with overactive bladder: US-based retrospective cohort study
por: Szabo, Shelagh M, et al.
Publicado: (2019)

Prevalence and Factors Associated with Cumulative Anticholinergic Burden Among Older Long-Stay Nursing Home Residents with Overactive Bladder
por: Chatterjee, Satabdi, et al.
Publicado: (2021)

Overactive Bladder Prescribing Considerations: The Role of Polypharmacy, Anticholinergic Burden, and CYP2D6 Drug‒Drug Interactions
por: Rutman, Matthew P., et al.
Publicado: (2021)

The Costs and Healthcare Resource Utilization Associated with Anticholinergic Burden in Long-Stay Nursing Home Residents with Overactive Bladder in the US
por: Chatterjee, Satabdi, et al.
Publicado: (2021)

Use of overactive bladder anticholinergic medications associated with falls leading to emergency department visits: results from the ADRED study
por: Just, Katja S., et al.
Publicado: (2023)

A 12-Year Retrospective Study of the Prevalence of Anticholinergic Polypharmacy and Associated Outcomes Among Medicare Patients with Overactive Bladder in the USA
por: Campbell, Noll L., et al.
Publicado: (2021)

Long-term efficacy and safety of vibegron versus mirabegron and anticholinergics for overactive bladder: a systematic review and network meta-analysis
por: Kennelly, Michael, et al.
Publicado: (2022)

Autonomous Nervous System Activity in Women with Detrusor Overactivity
por: Im, Hyun Wook, et al.
Publicado: (2010)

Corticosteroid-related central nervous system side effects
por: Ciriaco, Miriam, et al.
Publicado: (2013)

Assessment of Anticholinergic Use After Fading of BTX-A Effects in Refractory Idiopathic Overactive Bladder: A Prospective Blinded Randomized Trial
por: Elbaset, M.A., et al.
Publicado: (2019)

Management of Complications After Tension-Free Midurethral Slings
por: Çetinel, Bülent, et al.
Publicado: (2013)

Anticholinergics aggravate the imbalance of the autonomic nervous system in stable chronic obstructive pulmonary disease
por: Yuan, Wei, et al.
Publicado: (2019)

Is there a rationale and role for long-acting anticholinergic bronchodilators in asthma?
por: Price, David, et al.
Publicado: (2014)

Overactive bladder
por: Wallace, Karen M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_gnchi2165ali40ovq3pr85dec3